On 2024-05-07, Immuneering Corporation (IMRX) announced earnings per share of $-0.49 for the fiscal quarter ending 2024-03-31, missing the average analyst estimate of $-0.45.
The next expected annoucement date for quarterly earnings is 2024-08-01, with an average estimated earnings per share of $-0.49 for the fiscal quarter ending 2024-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-05-07 | 2024-03-31 | $-0.45 | $-0.49 |
| 2024-03-01 | 2023-12-31 | $-0.48 | $-0.52 |
| 2023-11-09 | 2023-09-30 | $-0.51 | $-0.43 |
| 2023-08-03 | 2023-06-30 | $-0.54 | $-0.43 |
| 2023-05-04 | 2023-03-31 | $-0.54 | $-0.51 |
| 2023-03-06 | 2022-12-31 | $-0.58 | $-0.50 |
| 2022-11-10 | 2022-09-30 | $-0.48 | $-0.49 |
| 2022-08-10 | 2022-06-30 | $-0.52 | $-0.44 |
| 2022-05-10 | 2022-03-31 | $-0.44 | $-0.49 |
| 2022-03-10 | 2021-12-31 | $-0.39 | $-0.42 |
| 2021-11-09 | 2021-09-30 | $-0.61 | $-0.47 |
| 2021-09-09 | 2021-06-30 | $-1.78 | $-1.61 |